Risk Factor Assessment for Acute Pulmonary Hypertension Crisis
Recruiting · NCT07653958 · Observational (researchers observe without assigning treatment) · Lead sponsor: Peking Union Medical College Hospital
View the official record on ClinicalTrials.gov →What this trial is about
The goal of this observational study is to learn about pulmonary hypertension crisis (PHC) - a severe, and often fatal complication - in patients with pulmonary hypertension (PH). The main questions this study aims to answer are: What are the clinical and hemodynamic features of PHC, and what underlying pathophysiological mechanisms cause it to develop? Can these features be used to diagnostic PHC, predict who is at risk of developing it or dying from it, and develop targeted prevention and treatment of PHC? A multi-center registry platform and biobank will be established to enroll and follow up patients with PH. Clinical data, hemodynamic measurements, and biological specimen will be collected. Risk prediction and early warning tools of PHC will be developed.
Who can take part
Inclusion criteria
- Pulmonary hypertension confirmed by mean pulmonary arterial pressure (mPAP) over 20 mmHg measured by right heart catheter
- At least once per year of follow-up data collection record
Exclusion criteria
- Patients with missing baseline or follow-up data
- Complicated by other diseases with significant influence on survival, such as acute coronary syndrome, malignancy, etc.
- Complicated by other diseases with significant influence on hemodynamics, such as sepsis, acute left heart failure, and acute pulmonary embolism, etc.
- Receiving medications with significant influence on hemodynamics
Where it is running
4 locations listed.
- Peking Union Medical College Hospital - Beijing, China
- Shanghai Pulmonary Hospital - Shanghai, China
- Guangdong Province People's Hospital - Guangzhou, Guangdong, China
- Yan'an Affiliated Hospital of Kunming Medical University - Kunming, Yunnan, China